MPM BIOVENTURES 2018, L.P. sold 2.0% of their position (86.91K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $615.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/31/2026ACC: 0001231919-26-001136
10% Owner
Since Oct 2021
-86.91K
Net shares
Net seller
$615.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
86.91K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−38.92K
Price / share
$7.20
Trade value
$280.24K
% of position
0.9%
8/27/2026
4.32M→4.28M
Common Stock
Indirect
Shares
−3.73K
Price / share
$7.01
Trade value
$26.17K
% of position
0.1%
8/28/2026
4.28M→4.28M
Common Stock
Indirect
Shares
−44.26K
Price / share
$6.99
Trade value
$309.37K
% of position
1.0%
8/31/2026
4.28M→4.23M
Total
Net shares
−86.91K
Net value
-$615.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/27/2026 | S · Sale | −38.92K | $7.20 | $280.24K | 0.9% | 4.32M | 4.28M |
| Common Stock Indirect | 8/28/2026 | S · Sale | −3.73K | $7.01 | $26.17K | 0.1% | 4.28M | 4.28M |
| Common Stock Indirect | 8/31/2026 | S · Sale | −44.26K | $6.99 | $309.37K | 1.0% | 4.28M | 4.23M |
| Total | −86.91K | -$615.78K | ||||||
Derivative Transactions0
No derivative transactions reported